EOLS vs PCRX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Apr 30, 2026
EOLS
PCRX
Investment Advisor Scores
PCRX
Apr 30, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | EOLS | PCRX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 52.0833 | 10.5152 | PCRX |
| PEG Ratio | 0 | 11.2121 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 14.4% | 5.1% | EOLS |
| Earnings Growth | 0.0% | -88.4% | EOLS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 61.8/100 | 62.2/100 | PCRX |
| Profit Margin | -17.4% | 1.0% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | BUY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EOLS
NeutralMixed signals - no dominant trend phase, RSI 46
PCRX
MarkupPrice above SMA50, rising 50-day trend (3.3% over 20 days), RSI 64
Fundamentals Snapshot
| Metric | EOLS | PCRX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 25.2 | 7.4 |
| Trailing P/E | — | 203.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.7% | 0.8% |
| Operating Margin | -0.1% | 0.0% |
| EPS | -0.66 | 0.13 |
| Dividend Yield | — | — |